Abstract
AbstractWe evaluated the tolerance of topical 0.5 % levobunolol in six patients with bilateral, open-angle glaucoma, who had developed signs of local irritation and allergy while receiving 0.5% timolol, twice daily. During treatment with levobunolol, four of the six patients did not experience an allergic reaction. Levobunolol successfully controlled intraocular pressure in all six patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Toxicology: Cutaneous and Ocular Toxicology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
